13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 35 holding rows worth $1,570,242,514.
- Accession
- 0001104659-24-089632
- Filer
- CIK 1615982
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 35 entries on the cover page, a total value of $1,570,242,514 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,570,242,514 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 8,493,321 | $334,212,181 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 4,026,331 | $94,095,355 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 4,400,000 | $92,356,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 12,762,462 | $87,295,240 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,173,913 | $76,717,390 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,263,214 | $74,744,372 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 6,249,731 | $73,621,831 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 3,395,606 | $63,837,393 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,685,448 | $63,134,882 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,094,373 | $54,202,373 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,882,671 | $50,513,550 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 5,684,167 | $47,917,528 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 9,542,871 | $44,565,208 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 16,216,216 | $38,270,270 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 3,608,645 | $32,838,670 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,818,182 | $32,745,458 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 4,394,527 | $31,069,306 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 706,131 | $29,205,578 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 2,825,983 | $26,649,020 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,379,965 | $24,066,590 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 3,410,058 | $23,222,495 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 11,328,000 | $22,769,280 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 6,023,166 | $21,081,081 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 9,000,000 | $20,160,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,345,780 | $17,791,212 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 627,788 | $16,711,717 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 5,555,555 | $14,444,443 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 5,389,259 | $13,742,610 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,563,952 | $11,698,361 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,422,637 | $10,199,458 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 1,467,048 | $10,063,949 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 750,000 | $7,545,000 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 1,555,556 | $4,822,224 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 00211Y506 | Stock | 866,375 | $3,318,216 | dollars as filed | |
| CASI PHARMACEUTICALS INC COM NEW | G1933S101 | Stock | 111,686 | $614,273 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-089632 | this filing | 2024-08-14 | acceptance time not in the bulk data set |